GlassScriptPhysician profile
Evan Fitchett
NPI 1073179461
$3,831.56
in general payments reported to CMS, 2019-2025
9 companies · $1,914 in 2025
The $1,914 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $143 · 2023: $1,164 · 2024: $611 · 2025: $1,914.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,527 · Travel and Lodging: $1,078 · Education: $83.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,526.78 |
| Travel and Lodging | $1,078.12 |
| Education | $83.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,050.39 | 2025 | |
| Stryker Corporation | $1,003.04 | 2023-2025 | Capri Corpectomy Cage System, Everest Spinal System, Cascadia Interbody System |
| Cerapedics INC. | $515.26 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic, INC. | $359.26 | 2022-2024 | Unid_pass, Pipeline |
| Si-Bone, INC. | $306.89 | 2023 | |
| Vb Spine LLC | $283.56 | 2025 | Xia 3 System - Serrato |
| Kuros Biosciences USA, INC | $180.23 | 2025 | Magnetos |
| Medical Device Business Services, INC. | $112.12 | 2024 | Matrixneuro |
| Paladin Technology Solutions | $20.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Fitchett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.